Skip to main navigation Skip to search Skip to main content

Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan

  • Mohamed Hassanein
  • , Akram Salim Echtay
  • , Rachid Malek
  • , Mahomed Omar
  • , Shehla Sajid Shaikh
  • , Magnus Ekelund
  • , Kadriye Kaplan
  • , Nor Azmi Kamaruddin
  • Rafik Hariri University
  • Ferhat Abbas Sétif University 1
  • University of KwaZulu-Natal
  • Prince Aly Khan Hospital
  • Novo Nordisk Foundation
  • Universiti Kebangsaan Malaysia

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science